DNA Methyltransferases and Gastric Cancer: Insight Into Targeted Therapy

References

• Sadikovic B , Al-RomaihK , SquireJA , ZielenskaM . Cause and consequences of genetic and epigenetic alterations in human cancer . Curr. Genomics9 ( 6 ), 394 – 408 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Akhavan-Niaki H , SamadaniAA . DNA methylation and cancer development: molecular mechanism . Cell Biochem. Biophys.67 ( 2 ), 501 – 513 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sharma S , KellyTK , JonesPA . Epigenetics in cancer . Carcinogenesis31 ( 1 ), 27 – 36 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Resende C , RistimakiA , MachadoJC . Genetic and epigenetic alteration in gastric carcinogenesis . Helicobacter15 ( Suppl. 1 ), 34 – 39 ( 2010 ).
   PubMedGoogle Scholar
• Nardone G , CompareD . Epigenetic alterations due to diet and Helicobacter pylori infection in gastric carcinogenesis . Expert Rev. Gastroenterol. Hepatol.2 ( 2 ), 243 – 248 ( 2008 ).
   PubMedGoogle Scholar
• Yang WY , GuJl , ZhenTM . Recent advances of histone modification in gastric cancer . J. Cancer Res. Ther.10 ( Suppl. ), 240 – 245 ( 2014 ).
   PubMedGoogle Scholar
• Zhang M , DuX . Noncoding RNAs in gastric cancer: research progress and prospects . World J. Gastroenterol.22 ( 29 ), 6610 – 6618 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Tahara T , ArisawaT . DNA methylation as a molecular biomarker in gastric cancer . Epigenomics7 ( 3 ), 475 – 486 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kunej T , GodnicI , FerdinJ , HorvatS , DovcP , CalinGA . Epigenetic regulation of microRNAs in cancer: an integrated review of literature . Mutat. Res.717 ( 1–2 ), 77 – 84 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wajed SA , LairdPW , DemeesterTR . DNA methylation: an alternative pathway to cancer . Ann. Surg.234 ( 1 ), 10 – 20 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Fernandez AF , HuidobroC , FragaMF . De novo DNA methyltransferases: oncogenes, tumor suppressors, or both?Trends Genet.28 ( 10 ), 474 – 479 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Fu DG . Epigenetic alterations in gastric cancer (review) . Mol. Med. Rep.12 ( 3 ), 3223 – 3230 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Qu Y , DangS , HouP . Gene methylation in gastric cancer . Clin. Chim. Acta424 , 53 – 65 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yang J , WeiX , WuQet al. Clinical significance of the expression of DNA methyltransferase proteins in gastric cancer . Mol. Med. Rep.4 ( 6 ), 1139 – 1143 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ding WJ , FangJY , ChenXY , PengYS . The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer . Dig. Dis. Sci.53 ( 8 ), 2083 – 2089 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Luczak MW , JagodzinskiPP . The role of DNA methylation in cancer development . Folia Histochem. Cytobiol.44 ( 3 ), 143 – 154 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Mccabe MT , BrandesJC , VertinoPM . Cancer DNA methylation: molecular mechanisms and clinical implications . Clin. Cancer Res.15 ( 12 ), 3927 – 3937 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Lyko F . The DNA methyltransferase family: a versatile toolkit for epigenetic regulation . Nat. Rev. Genet.19 ( 2 ), 81 – 92 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Rountree MR , BachmanKE , BaylinSB . DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci . Nat. Genet.25 ( 3 ), 269 – 277 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Egger G , JeongS , EscobarSGet al. Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival . Proc. Natl Acad. Sci. USA103 ( 38 ), 14080 – 14085 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Garvilles RG , HasegawaT , KimuraHet al. Dual functions of the RFTS domain of DNMT1 in replication-coupled DNA methylation and in protection of the genome from aberrant methylation . PLoS ONE10 ( 9 ), e0137509 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Syeda F , FaganRL , WeanMet al. The replication focus targeting sequence (RFTS) domain is a DNA-competitive inhibitor of DNMT1 . J. Biol. Chem.286 ( 17 ), 15344 – 15351 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Pradhan M , EstevePO , ChinHG , SamaranaykeM , KimGD , PradhanS . CXXC domain of human DNMT1 is essential for enzymatic activity . Biochemistry47 ( 38 ), 10000 – 10009 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Callebaut I , CourvalinJC , MornonJP . The BAH (bromo-adjacent homology) domain: a link between DNA methylation, replication and transcriptional regulation . FEBS Lett.446 ( 1 ), 189 – 193 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Jeltsch A , JurkowskaRZ . Allosteric control of mammalian DNA methyltransferases – a new regulatory paradigm . Nucleic Acids Res.44 ( 18 ), 8556 – 8575 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Okano M , XieS , LiE . Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases . Nat. Genet.19 ( 3 ), 219 – 220 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Xie S , WangZ , OkanoMet al. Cloning, expression and chromosome locations of the human DNMT3 gene family . Gene236 ( 1 ), 87 – 95 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Dhayalan A , RajaveluA , RathertPet al. The DNMT3a PWWP domain reads histone 3 lysine 36 trimethylation and guides DNA methylation . J. Biol. Chem.285 ( 34 ), 26114 – 26120 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Chen T , TsujimotoN , LiE . The PWWP domain of DNMT3a and DNMT3b is required for directing DNA methylation to the major satellite repeats at pericentric heterochromatin . Mol. Cell Biol.24 ( 20 ), 9048 – 9058 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Argentaro A , YangJC , ChapmanLet al. Structural consequences of disease-causing mutations in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX . Proc. Natl Acad. Sci. USA104 ( 29 ), 11939 – 11944 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Dhayalan A , TamasR , BockIet al. The ATRX-ADD domain binds to H3 tail peptides and reads the combined methylation state of K4 and K9 . Hum. Mol. Genet.20 ( 11 ), 2195 – 2203 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Otani J , NankumoT , AritaK , InamotoS , AriyoshiM , ShirakawaM . Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX-DNMT3-DNMT3L domain . EMBO Rep.10 ( 11 ), 1235 – 1241 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Toyota M , YamamotoE . DNA methylation changes in cancer . Prog. Mol. Biol. Transl. Sci.101 , 447 – 457 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wang H , DuanXl , QiXLet al. Concurrent hypermethylation of SFRP2 and DKK2 activates the Wnt/beta-catenin pathway and is associated with poor prognosis in patients with gastric cancer . Mol. Cells40 ( 1 ), 45 – 53 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Chiurillo MA . Role of the Wnt/beta-catenin pathway in gastric cancer: an in-depth literature review . World J. Exp. Med.5 ( 2 ), 84 – 102 ( 2015 ).
   PubMedGoogle Scholar
• Ersahin T , TuncbagN , Cetin-AtalayR . The PI3K/AKT/mTOR interactive pathway . Mol. Biosyst.11 ( 7 ), 1946 – 1954 ( 2015 ).
   PubMedGoogle Scholar
• Matsuoka T , YashiroM . The role of PI3K/Akt/mTOR signaling in gastric carcinoma . Cancers (Basel)6 ( 3 ), 1441 – 1463 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Du W , WangS , ZhouQet al. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer . Oncogene32 ( 28 ), 3319 – 3328 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Singh SS , YapWN , ArfusoFet al. Targeting the PI3K/Akt signaling pathway in gastric carcinoma: a reality for personalized medicine? World J. Gastroenterol. 21 ( 43 ), 12261 – 12273 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Huang T , ZhouY , ChengAS , YuJ , ToKF , KangW . NOTCH receptors in gastric and other gastrointestinal cancers: oncogenes or tumor suppressors?Mol. Cancer15 ( 1 ), 80 ( 2016 ).
   PubMedGoogle Scholar
• Piazzi G , FiniL , SelgradMet al. Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer . Oncotarget2 ( 12 ), 1291 – 1301 ( 2011 ).
   PubMedGoogle Scholar
• Piazzi G , BazzoliF , RicciardielloL . Epigenetic silencing of Notch signaling in gastrointestinal cancers . Cell Cycle11 ( 23 ), 4323 – 4327 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Yeh TS , WuCW , HsuKWet al. The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2 . Cancer Res.69 ( 12 ), 5039 – 5048 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Brzozowa M , MielanczykL , MichalskiMet al. Role of Notch signaling pathway in gastric cancer pathogenesis . Contemp. Oncol. (Pozn.)17 ( 1 ), 1 – 5 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yao Y , NiY , ZhangJ , WangH , ShaoS . The role of Notch signaling in gastric carcinoma: molecular pathogenesis and novel therapeutic targets . Oncotarget8 ( 32 ), 53839 – 53853 ( 2017 ).
   PubMedGoogle Scholar
• Yu W , LiX , EliasonSet al. IRX1 regulates dental outer enamel epithelial and lung alveolar type II epithelial differentiation . Dev. Biol.429 ( 1 ), 44 – 55 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Guo X , LiuW , PanYet al. Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma . Oncogene29 ( 27 ), 3908 – 3920 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Lai J , WangH , LuoQet al. The relationship between DNA methylation and Reprimo gene expression in gastric cancer cells . Oncotarget8 ( 65 ), 108610 – 108623 ( 2017 ).
   PubMedGoogle Scholar
• Etoh T , KanaiY , UshijimaSet al. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers . Am. J. Pathol.164 ( 2 ), 689 – 699 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Jung Y , ParkJ , KimTYet al. Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy . J. Mol. Med. (Berl.)85 ( 10 ), 1137 – 1148 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Waki T , TamuraG , TsuchiyaT , SatoK , NishizukaS , MotoyamaT . Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia . Am. J. Pathol.161 ( 2 ), 399 – 403 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Deng J , LiangH , ZhangRet al. Applicability of the methylated CpG sites of paired box 5 (PAX5) promoter for prediction the prognosis of gastric cancer . Oncotarget5 ( 17 ), 7420 – 7430 ( 2014 ).
   PubMedGoogle Scholar
• Cheng AS , LiMS , KangWet al. Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis . Gastroenterology144 ( 1 ), 122 – 133 e129 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Shi H , WangX , WangJ , PanJ , LiuJ , YeB . Association between CHFR gene hypermethylation and gastric cancer risk: a meta-analysis . Onco. Targets Ther.9 , 7409 – 7414 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Chen HY , ZhuBH , ZhangCHet al. High CpG island methylator phenotype is associated with lymph node metastasis and prognosis in gastric cancer . Cancer Sci.103 ( 1 ), 73 – 79 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Yamashita S , TsujinoY , MoriguchiK , TatematsuM , UshijimaT . Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2′-deoxycytidine treatment and oligonucleotide microarray . Cancer Sci.97 ( 1 ), 64 – 71 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Li Y , YangY , LuYet al. Predictive value of CHFR and MLH1 methylation in human gastric cancer . Gastric Cancer18 ( 2 ), 280 – 287 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Jia W , YuT , CaoX , AnQ , YangH . Clinical effect of DAPK promoter methylation in gastric cancer: a systematic meta-analysis . Medicine (Baltimore)95 ( 43 ), e5040 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Zazula M , FerreiraAM , CzopekJPet al. CDH1 gene promoter hypermethylation in gastric cancer: relationship to Goseki grading, microsatellite instability status, and EBV invasion . Diagn. Mol. Pathol.15 ( 1 ), 24 – 29 ( 2006 ).
   PubMedGoogle Scholar
• Tao K , WuC , WuKet al. Quantitative analysis of promoter methylation of the EDNRB gene in gastric cancer . Med. Oncol.29 ( 1 ), 107 – 112 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Buffart TE , OvermeerRM , SteenbergenRDet al. MAL promoter hypermethylation as a novel prognostic marker in gastric cancer . Br. J. Cancer99 ( 11 ), 1802 – 1807 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Hu XT , ZhangFB , FanYCet al. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer . Oncogene28 ( 26 ), 2466 – 2475 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Kim M , JangHR , HaamKet al. Frequent silencing of popeye domain-containing genes, BVES and POPDC3, is associated with promoter hypermethylation in gastric cancer . Carcinogenesis31 ( 9 ), 1685 – 1693 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Li Z , ChimJC , YangM , YeJ , WongBC , QiaoL . Role of PCDH10 and its hypermethylation in human gastric cancer . Biochim. Biophys. Acta1823 ( 2 ), 298 – 305 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Oishi Y , WatanabeY , YoshidaYet al. Hypermethylation of Sox17 gene is useful as a molecular diagnostic application in early gastric cancer . Tumour Biol.33 ( 2 ), 383 – 393 ( 2012 ).
   PubMedGoogle Scholar
• Liu X , WangX , ZhangJet al. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis . Oncogene29 ( 3 ), 442 – 450 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Kim M , KimJH , JangHRet al. LRRC3B, encoding a leucine-rich repeat-containing protein, is a putative tumor suppressor gene in gastric cancer . Cancer Res.68 ( 17 ), 7147 – 7155 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Cheng YY , JinH , LiuXet al. Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer . Br. J. Cancer99 ( 12 ), 2083 – 2087 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Wanajo A , SasakiA , NagasakiHet al. Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer . Gastroenterology135 ( 2 ), 580 – 590 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Wu CS , LuYJ , LiHPet al. Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer . Int. J. Cancer126 ( 11 ), 2542 – 2552 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Dong W , FengL , XieY , ZhangH , WuY . Hypermethylation-mediated reduction of LMX1A expression in gastric cancer . Cancer Sci.102 ( 2 ), 361 – 366 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Chen H , PanY , ChengZYet al. Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer . Asian Pac. J. Cancer Prev.14 ( 11 ), 6261 – 6265 ( 2013 ).
   PubMedGoogle Scholar
• Jiang P , YuG , ZhangYet al. Promoter hypermethylation and downregulation of trefoil factor 2 in human gastric cancer . Oncol. Lett.7 ( 5 ), 1525 – 1531 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Waraya M , YamashitaK , KatohHet al. Cancer specific promoter CpG Islands hypermethylation of HOP homeobox (HOPX) gene and its potential tumor suppressive role in pancreatic carcinogenesis . BMC Cancer12 , 397 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Akiyama Y , WatkinsN , SuzukiHet al. GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer . Mol. Cell Biol.23 ( 23 ), 8429 – 8439 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Du YY , DaiDQ , YangZ . Role of RECK methylation in gastric cancer and its clinical significance . World J. Gastroenterol.16 ( 7 ), 904 – 908 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Kim H , KimYH , KimSE , KimNG , NohSH , KimH . Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability . J. Pathol.200 ( 1 ), 23 – 31 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Dohi O , TakadaH , WakabayashiNet al. Epigenetic silencing of RELN in gastric cancer . Int. J. Oncol.36 ( 1 ), 85 – 92 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Du P , YeHR , GaoJet al. Methylation of PTCH1a gene in a subset of gastric cancers . World J. Gastroenterol.15 ( 30 ), 3799 – 3806 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Kim M , LeeKT , JangHRet al. Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion . Mol. Cancer Res.6 ( 2 ), 222 – 230 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Wang G , ZhangW , ZhouBet al. The diagnosis value of promoter methylation of UCHL1 in the serum for progression of gastric cancer . Biomed. Res. Int. 2015 , 741030 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Mikata R , FukaiK , ImazekiFet al. BCL2L10 is frequently silenced by promoter hypermethylation in gastric cancer . Oncol. Rep.23 ( 6 ), 1701 – 1708 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Shi X , LiX , ChenL , WangC . Analysis of somatostatin receptors and somatostatin promoter methylation in human gastric cancer . Oncol. Lett.6 ( 6 ), 1794 – 1798 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Liu Y , ChewMH , ThamCK , TangCL , OngSY , ZhaoY . Methylation of serum SST gene is an independent prognostic marker in colorectal cancer . Am. J. Cancer Res.6 ( 9 ), 2098 – 2108 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Wen XZ , AkiyamaY , BaylinSB , YuasaY . Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas . Oncogene25 ( 18 ), 2666 – 2673 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Kim SK , JangHR , KimJHet al. The epigenetic silencing of LIMS2 in gastric cancer and its inhibitory effect on cell migration . Biochem. Biophys. Res. Commun.349 ( 3 ), 1032 – 1040 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Kim ST , JangHL , LeeJet al. Clinical significance of IGFBP-3 methylation in patients with early stage gastric cancer . Transl. Oncol.8 ( 4 ), 288 – 294 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Wang LH , KimSH , LeeJHet al. Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression . Clin. Cancer Res.13 ( 1 ), 102 – 110 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Noda H , MiyajiY , NakanishiA , KonishiF , MikiY . Frequent reduced expression of alpha-1B-adrenergic receptor caused by aberrant promoter methylation in gastric cancers . Br. J. Cancer96 ( 2 ), 383 – 390 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Kato K , IidaS , UetakeHet al. Methylated TMS1 and DAPK genes predict prognosis and response to chemotherapy in gastric cancer . Int. J. Cancer122 ( 3 ), 603 – 608 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Su Y , LinY , ZhangLet al. CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancer . Cancer Sci.105 ( 1 ), 26 – 34 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kim J , MinSY , LeeHE , KimWH . Aberrant DNA methylation and tumor suppressive activity of the EBF3 gene in gastric carcinoma . Int. J. Cancer130 ( 4 ), 817 – 826 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Leung WK , YuJ , BaiAHet al. Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer . Mol. Carcinog.37 ( 2 ), 91 – 97 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Akino K , ToyotaM , SuzukiHet al. Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer . Cancer Sci.98 ( 1 ), 88 – 95 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Da MX , ZhangYB , YaoJB , DuanYX . DNA methylation regulates expression of VEGF-C, and S-adenosylmethionine is effective for VEGF-C methylation and for inhibiting cancer growth . Braz. J. Med. Biol. Res.47 ( 12 ), 1021 – 1028 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Jin SH , AkiyamaY , FukamachiH , YanagiharaK , AkashiT , YuasaY . IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells . Int. J. Cancer122 ( 5 ), 1040 – 1046 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Otsubo T , AkiyamaY , YanagiharaK , YuasaY . SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis . Br. J. Cancer98 ( 4 ), 824 – 831 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Wang L , ZhuJS , SongMQ , ChenGQ , ChenJL . Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray . World J. Gastroenterol.12 ( 43 ), 6949 – 6954 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Cui Y , YingY , Van HasseltAet al. OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation . PLoS ONE3 ( 8 ), e2990 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Fang DC , LuoYH , YangSM , LiXA , LingXL , FangL . Mutation analysis of APC gene in gastric cancer with microsatellite instability . World J. Gastroenterol.8 ( 5 ), 787 – 791 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Campbell PM , SzyfM . Human DNA methyltransferase gene DNMT1 is regulated by the APC pathway . Carcinogenesis24 ( 1 ), 17 – 24 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Hmadcha A , BedoyaFJ , SobrinoF , PintadoE . Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production . J. Exp. Med.190 ( 11 ), 1595 – 1604 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Huang FY , ChanAO , RashidA , WongDK , ChoCH , YuenMF . Helicobacter pylori induces promoter methylation of E-cadherin via interleukin-1beta activation of nitric oxide production in gastric cancer cells . Cancer118 ( 20 ), 4969 – 4980 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Fattahi S , NikbakhshN , TaheriHet al. Prevalence of multiple infections and the risk of gastric adenocarcinoma development at earlier age . Diagn. Microbiol. Infect. Dis.92 ( 1 ), 62 – 68 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Fattahi S , Kosari-MonfaredM , GhadamiEet al. Infection-associated epigenetic alterations in gastric cancer: new insight in cancer therapy . J. Cell Physiol.233 ( 12 ), 9261 – 9270 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Zeng ZM , LuoFF , ZouLXet al. Human papillomavirus as a potential risk factor for gastric cancer: a meta-analysis of 1,917 cases . Oncol. Targets Ther.9 , 7105 – 7114 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Snietura M , WaniczekD , PiglowskiWet al. Potential role of human papilloma virus in the pathogenesis of gastric cancer . World J. Gastroenterol.20 ( 21 ), 6632 – 6637 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Au Yeung CL , TsangWP , TsangTY , CoNN , YauPL , KwokTT . HPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53 . Oncol. Rep.24 ( 6 ), 1599 – 1604 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Lin RK , WuCY , ChangJWet al. Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer . Cancer Res.70 ( 14 ), 5807 – 5817 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Tang Y-A , TsaiY-T , LinR-K , HsuH-S , ChenC-Y , WangY-C . Deregulation of p53 and RB transcriptional control leads to overexpression of DNA methyltransferases in lung cancer . J. Cancer Res. Pract.1 ( 1 ), 14 – 27 ( 2014 ).
   Google Scholar
• Zhang BG , HuL , ZangMDet al. Helicobacter pylori CagA induces tumor suppressor gene hypermethylation by upregulating DNMT1 via AKT-NFkappaB pathway in gastric cancer development . Oncotarget7 ( 9 ), 9788 – 9800 ( 2016 ).
   PubMedGoogle Scholar
• Wang H-C , ChenC-W , YangC-Let al. Tumor-associated macrophages promote epigenetic silencing of gelsolin through DNA methyltransferase 1 in gastric cancer cells . Cancer Immunol. Res.5 ( 10 ), 885 – 897 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Baj-Krzyworzeka M , WeglarczykK , BaranJ , SzczepanikA , SzuraM , SiedlarM . Elevated level of some chemokines in plasma of gastric cancer patients . Cent. Eur. J. Immunol.41 ( 4 ), 358 – 362 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Wang T , WeiY , TianLet al. C-C motif chemokine ligand 5 (CCL5) levels in gastric cancer patient sera predict occult peritoneal metastasis and a poorer prognosis . Int. J. Surg.32 , 136 – 142 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Kudo T , LuH , WuJY , GrahamDY , CasolaA , YamaokaY . Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori . Infect. Immun.73 ( 11 ), 7602 – 7612 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Nakayama T , HieshimaK , NagakuboDet al. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein–Barr virus . J Virol78 ( 4 ), 1665 – 1674 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Westrich JA , WarrenCJ , PyeonD . Evasion of host immune defenses by human papillomavirus . Virus Res.231 , 21 – 33 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Cao XY , MaHX , ShangYHet al. DNA methyltransferase3a expression is an independent poor prognostic indicator in gastric cancer . World J. Gastroenterol.20 ( 25 ), 8201 – 8208 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Huang F-Y , ChanAO-O , LoRC-Let al. Characterization of interleukin-1β in Helicobacter pylori-induced gastric inflammation and DNA methylation in interleukin-1 receptor type 1 knockout (IL-1R1−/−) mice . Eur. J. Cancer49 ( 12 ), 2760 – 2770 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• El-Omar EM , CarringtonM , ChowWHet al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer . Nature404 ( 6776 ), 398 – 402 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Valenzuela MA , CanalesJ , CorvalanAH , QuestAF . Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis . World J. Gastroenterol.21 ( 45 ), 12742 – 12756 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Ishii Y , ShibataW , SugimoriMet al. Activation of signal transduction and activator of transcription 3 signaling contributes to Helicobacter-associated gastric epithelial proliferation and inflammation . Gastroenterol. Res. Pract. 2018 , 9050715 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Kang HJ , YiYW , HouSJet al. Disruption of STAT3–DNMT1 interaction by SH-I-14 induces re-expression of tumor suppressor genes and inhibits growth of triple-negative breast tumor . Oncotarget8 ( 48 ), 83457 – 83468 ( 2017 ).
   PubMedGoogle Scholar
• Maekita T , NakazawaK , MiharaMet al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk . Clin. Cancer Res.12 ( 3 Pt 1 ), 989 – 995 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Ando T , YoshidaT , EnomotoSet al. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect . Int. J. Cancer124 ( 10 ), 2367 – 2374 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Niwa T , TsukamotoT , ToyodaTet al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells . Cancer Res.70 ( 4 ), 1430 – 1440 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Maeda M , MoroH , UshijimaT . Mechanisms for the induction of gastric cancer by Helicobacter pylori infection: aberrant DNA methylation pathway . Gastric Cancer20 ( Suppl. 1 ), 8 – 15 ( 2017 ).
   PubMedGoogle Scholar
• Piao JY , LeeHG , KimSJet al. Helicobacter pylori activates IL-6-STAT3 signaling in human gastric cancer cells: potential roles for reactive oxygen species . Helicobacter21 ( 5 ), 405 – 416 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Zhang Q , WangHY , WoetmannA , RaghunathPN , OdumN , WasikMA . STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes . Blood108 ( 3 ), 1058 – 1064 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Lee H , ZhangP , HerrmannAet al. Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation . Proc. Natl Acad. Sci. USA109 ( 20 ), 7765 – 7769 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wang HC , ChenCW , YangCLet al. Tumor-associated macrophages promote epigenetic silencing of gelsolin through DNA methyltransferase 1 in gastric cancer cells . Cancer Immunol. Res.5 ( 10 ), 885 – 897 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Hino R , UozakiH , MurakamiNet al. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma . Cancer Res.69 ( 7 ), 2766 – 2774 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Zhao J , LiangQ , CheungKFet al. Genome-wide identification of Epstein–Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells . Cancer119 ( 2 ), 304 – 312 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Tsai CL , LiHP , LuYJet al. Activation of DNA methyltransferase 1 by EBV LMP1 involves c-Jun NH(2)-terminal kinase signaling . Cancer Res.66 ( 24 ), 11668 – 11676 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Li H , LiW , LiuSet al. DNMT1, DNMT3A and DNMT3B polymorphisms associated with gastric cancer risk: a systematic review and meta-analysis . EBioMedicine13 , 125 – 131 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Shastry BS . SNPs: impact on gene function and phenotype . Methods Mol. Biol.578 , 3 – 22 ( 2009 ).
   PubMedGoogle Scholar
• Wang C , JiaZ , MaHet al. DNA methyltransferase 3a rs1550117 genetic polymorphism predicts poor survival in gastric cancer patients . Int. J. Clin. Exp. Pathol.8 ( 11 ), 14864 – 14874 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Zhang Y , XuH , ShenY , GongZ , XiaoT . Association of DNMT3B -283 T > C and -579 G > T polymorphisms with decreased cancer risk: evidence from a meta-analysis . Int. J. Clin. Exp. Med.8 ( 8 ), 13028 – 13038 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Zhu J , DuS , ZhangJ , WangY , WuQ , NiJ . Polymorphism of DNA methyltransferase 3B -149C/T and cancer risk: a meta-analysis . Med. Oncol.32 ( 1 ), 399 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Liu Z , WangL , WangLE , SturgisEM , WeiQ . Polymorphisms of the DNMT3B gene and risk of squamous cell carcinoma of the head and neck: a case-control study . Cancer Lett.268 ( 1 ), 158 – 165 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Singal R , DasPM , ManoharanM , ReisIM , SchlesselmanJJ . Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk . Oncol. Rep.14 ( 2 ), 569 – 573 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Montgomery KG , LiuMC , EcclesDM , CampbellIG . The DNMT3B C–>T promoter polymorphism and risk of breast cancer in a British population: a case–control study . Breast Cancer Res.6 ( 4 ), R390 – 394 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Zhang S-H , YangL-H , MaX-M . Association between SNP (149C/T) of DNMT3B gene and the risk of lung cancer in Jiamusi . Chin. J. Gerontol.31 , 4090 – 4092 ( 2011 ).
   Google Scholar
• Hu J , FanH , LiuD , ZhangS , ZhangF , XuH . DNMT3B promoter polymorphism and risk of gastric cancer . Dig. Dis. Sci.55 ( 4 ), 1011 – 1016 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Chen B , WangJ , GuX , ZhangJ , ZhangJ , FengX . The DNMT3B -579G>T polymorphism is significantly associated with the risk of gastric cancer but not lung cancer in Chinese population . Technol. Cancer Res. Treat.16 ( 6 ), 1259 – 1265 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Zhou J , ZhiX , WangLet al. Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway . J. Exp. Clin. Cancer Res.34 , 135 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Ahmadi K , SoleimaniA , IraniSet al. DNMT3B -579 G>T promoter polymorphism and the risk of gastric cancer in the West of Iran . J. Gastrointest. Cancer49 ( 2 ), 167 – 171 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Aung PP , MatsumuraS , KuraokaKet al. No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population . Oncol. Rep.14 ( 5 ), 1151 – 1154 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Wang YM , WangR , WenDGet al. Single nucleotide polymorphism in DNA methyltransferase 3B promoter and its association with gastric cardiac adenocarcinoma in North China . World J. Gastroenterol.11 ( 23 ), 3623 – 3627 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Yang XX , HeXQ , LiFX , WuYS , GaoY , LiM . Risk-association of DNA methyltransferases polymorphisms with gastric cancer in the Southern Chinese population . Int. J. Mol. Sci.13 ( 7 ), 8364 – 8378 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Jia Z , WuX , CaoDet al. Polymorphisms of the DNA methyltransferase 1 gene predict survival of gastric cancer patients receiving tumorectomy . Dis. Markers 2016 , 8578064 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Jiang J , JiaZ , CaoDet al. Polymorphisms of the DNA methyltransferase 1 associated with reduced risks of Helicobacter pylori infection and increased risks of gastric atrophy . PLoS ONE7 ( 9 ), e46058 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Cao XY , JiaZF , CaoDHet al. DNMT3a rs1550117 polymorphism association with increased risk of Helicobacter pylori infection . Asian Pac. J. Cancer Prev.14 ( 10 ), 5713 – 5718 ( 2013 ).
   PubMedGoogle Scholar
• Paraskevopoulou MD , GeorgakilasG , KostoulasNet al. DIANA-microT web server v5. 0: service integration into miRNA functional analysis workflows . Nucleic Acids Res.41 ( W1 ), W169 – W173 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bhattacharya A , ZiebarthJD , CuiY . PolymiRTS Database 3.0: linking polymorphisms in microRNAs and their target sites with human diseases and biological pathways . Nucleic Acids Res.42 ( D1 ), D86 – D91 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Gong J , LiuC , LiuWet al. An update of miRNASNP database for better SNP selection by GWAS data, miRNA expression and online tools . Database (Oxford) 2015 , bav029 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Su Y , NiZ , WangGet al. Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p . Int. Immunopharmacol.13 ( 4 ), 468 – 475 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zhang R , WangM , SuiP , DingL , YangQ . Upregulation of microRNA-574-3p in a human gastric cancer cell line AGS by TGF-beta1 . Gene605 , 63 – 69 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Duan Y , HuL , LiuBet al. Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV . Mol. Cancer13 , 127 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Wu H , ZhangK , GongPet al. A novel functional TagSNP Rs7560488 in the DNMT3A1 promoter is associated with susceptibility to gastric cancer by modulating promoter activity . PLoS ONE9 ( 3 ), e92911 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Wu Q , LuS , WangLet al. DNMT3A rs36012910 A>G polymorphism and gastric cancer susceptibility in a Chinese population . Mol. Biol. Rep.39 ( 12 ), 10949 – 10955 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Fan H , LiuD , QiuXet al. A functional polymorphism in the DNA methyltransferase-3A promoter modifies the susceptibility in gastric cancer but not in esophageal carcinoma . BMC Med.8 , 12 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Khatami F , NoorinayerB , GhiasiS , MohebiR , HashemiM , ZaliMR . Lack of effects of single nucleotide polymorphisms of the DNA methyltransferase 1 gene on gastric cancer in Iranian patients: a case control study . Asian Pac. J. Cancer Prev.10 ( 6 ), 1177 – 1182 ( 2009 ).
   PubMedGoogle Scholar
• Wang C , JiaZ , CaoDet al. Polymorphism of DNA methyltransferase 3b and association with development and prognosis in gastric cancer . PLoS ONE10 ( 8 ), e0134059 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Khan FA , ShuklaAN . Pathogenesis and treatment of gastric carcinoma: “an up-date with brief review” . J. Cancer Res. Ther.2 ( 4 ), 196 – 199 ( 2006 ).
   PubMedGoogle Scholar
• Winkelmann J , LinL , SchormairBet al. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy . Hum. Mol. Genet21 ( 10 ), 2205 – 2210 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Maresca A , ZaffagniniM , CaporaliL , CarelliV , ZannaC . DNA methyltransferase 1 mutations and mitochondrial pathology: is mtDNA methylated?Front. Genet.6 , 90 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Milutinovic S , BrownSE , ZhuangQ , SzyfM . DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation . J. Biol. Chem.279 ( 27 ), 27915 – 27927 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Ley TJ , DingL , WalterMJet al. DNMT3A mutations in acute myeloid leukemia . N. Engl. J. Med.363 ( 25 ), 2424 – 2433 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Fang X , PoulsenRR , Wang-HuJet al. Knockdown of DNA methyltransferase 3a alters gene expression and inhibits function of embryonic cardiomyocytes . FASEB J.30 ( 9 ), 3238 – 3255 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Gao Q , SteineEJ , BarrasaMIet al. Deletion of the de novo DNA methyltransferase DNMT3a promotes lung tumor progression . Proc. Natl Acad. Sci. USA108 ( 44 ), 18061 – 18066 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Manasa P . Epigenetics – role as biomarker in cancer diagnosis . Adv. Oncol. Res. Treat.2 , r001 ( 2016 ).
   Google Scholar
• Oshimo Y , KuraokaK , NakayamaHet al. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma . Int. J. Cancer112 ( 6 ), 1003 – 1009 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Zhao J , ZhaoD , PoageGMet al. Death-associated protein kinase 1 promotes growth of p53-mutant cancers . J. Clin. Invest.125 ( 7 ), 2707 – 2720 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Asada K , NakajimaT , ShimazuTet al. Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study . Gut64 ( 3 ), 388 – 396 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Urakami S , ShiinaH , EnokidaHet al. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection . Clin. Cancer Res.12 ( 7 Pt 1 ), 2109 – 2116 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Hsu HS , ChenTP , HungCHet al. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma . Cancer110 ( 9 ), 2019 – 2026 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Koizumi W . Chemotherapy for advanced gastric cancer: review of global and Japanese status . Gastrointest. Cancer Res.1 ( 5 ), 197 – 203 ( 2007 ).
   PubMedGoogle Scholar
• Housman G , BylerS , HeerbothSet al. Drug resistance in cancer: an overview . Cancers (Basel)6 ( 3 ), 1769 – 1792 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Mutze K , LangerR , SchumacherFet al. DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer . Eur. J. Cancer47 ( 12 ), 1817 – 1825 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lee KD , PaiMY , HsuCCet al. Targeted Casp8AP2 methylation increases drug resistance in mesenchymal stem cells and cancer cells . Biochem. Biophys. Res. Commun.422 ( 4 ), 578 – 585 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Maeda O , AndoT , OhmiyaNet al. Alteration of gene expression and DNA methylation in drug-resistant gastric cancer . Oncol. Rep.31 ( 4 ), 1883 – 1890 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Moertel CG , SchuttAJ , ReitemeierRJ , HahnRG . Phase II study of 5-azacytidine (NSC-102816) in the treatment of advanced gastrointestinal cancer . Cancer Chemother. Rep.56 ( 5 ), 649 – 652 ( 1972 ).
   PubMedGoogle Scholar
• Schneider BJ , ShahMA , KluteKet al. Phase I study of epigenetic priming with azacitidine prior to standard neoadjuvant chemotherapy for patients with resectable gastric and esophageal adenocarcinoma: evidence of tumor hypomethylation as an indicator of major histopathologic response . Clin. Cancer Res.23 ( 11 ), 2673 – 2680 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Duenas-Gonzalez A , Medina-FrancoJL , Chavez-BlancoA , Dominguez-GomezG , Fernandez-De GortariE . Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers . Expert Opin. Pharmacother.17 ( 3 ), 323 – 338 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Tan W , ZhouW , YuHG , LuoHS , ShenL . The DNA methyltransferase inhibitor zebularine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo . Biochem. Biophys. Res. Commun.430 ( 1 ), 250 – 255 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wu FL , LiRT , YangMet al. Gelatinases-stimuli nanoparticles encapsulating 5-fluorouridine and 5-aza-2′-deoxycytidine enhance the sensitivity of gastric cancer cells to chemical therapeutics . Cancer Lett.363 ( 1 ), 7 – 16 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Zhang X , YashiroM , OhiraM , RenJ , HirakawaK . Synergic antiproliferative effect of DNA methyltransferase inhibitor in combination with anticancer drugs in gastric carcinoma . Cancer Sci.97 ( 9 ), 938 – 944 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Li YC , WangY , LiDD , ZhangY , ZhaoTC , LiCF . Procaine is a specific DNA methylation inhibitor with anti-tumor effect for human gastric cancer . J. Cell Biochem.119 ( 2 ), 2440 – 2449 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Erdmann A , MenonY , GrosCet al. Identification and optimization of hydrazone-gallate derivatives as specific inhibitors of DNA methyltransferase 3A . Future Med. Chem.8 ( 4 ), 373 – 380 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Xie Q , BaiQ , ZouLYet al. Genistein inhibits DNA methylation and increases expression of tumor suppressor genes in human breast cancer cells . Genes Chromosomes Cancer53 ( 5 ), 422 – 431 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Pan W , ZhuS , YuanMet al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1 . J. Immunol.184 ( 12 ), 6773 – 6781 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Li Z , LiD , ZhangGet al. Methylation-associated silencing of MicroRNA-335 contributes tumor cell invasion and migration by interacting with RASA1 in gastric cancer . Am. J. Cancer Res.4 ( 6 ), 648 – 662 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zuo J , XiaJ , JuFet al. MicroRNA-148a can regulate runt-related transcription factor 3 gene expression via modulation of DNA methyltransferase 1 in gastric cancer . Mol. Cells35 ( 4 ), 313 – 319 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Zhang G , EstevePO , ChinHGet al. Small RNA-mediated DNA (cytosine-5) methyltransferase 1 inhibition leads to aberrant DNA methylation . Nucleic Acids Res.43 ( 12 ), 6112 – 6124 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Ooki A , YamashitaK , YamaguchiK , MondalA , NishimiyaH , WatanabeM . DNA damage-inducible gene, reprimo functions as a tumor suppressor and is suppressed by promoter methylation in gastric cancer . Mol. Cancer Res.11 ( 11 ), 1362 – 1374 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Liu J , XieY-S , WangF-L , ZhangL-J , ZhangY , LuoH-S . Cytotoxicity of 5-Aza-2′-deoxycytidine against gastric cancer involves DNA damage in an ATM-P53 dependent signaling pathway and demethylation of P16(INK4A) . Biomed. Pharmacother.67 ( 1 ), 78 – 87 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Liu J , ZhangY , XieYSet al. 5-Aza-2′-deoxycytidine induces cytotoxicity in BGC-823 cells via DNA methyltransferase 1 and 3a independent of p53 status . Oncol. Rep.28 ( 2 ), 545 – 552 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Eun JW , KimHS , ShenQet al. MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis . J. Pathol.244 ( 1 ), 107 – 119 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Shi H , ChenX , JiangHet al. miR-148a suppresses cell invasion and migration in gastric cancer by targeting DNA methyltransferase 1 . Oncol. Lett.15 ( 4 ), 4944 – 4950 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Lin S , LinB , WangXet al. Silencing of ATP4B of ATPase H(+)/K(+) transporting beta subunit by intragenic epigenetic alteration in human gastric cancer cells . Oncol. Res.25 ( 3 ), 317 – 329 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Valentini V , CelliniF . Radiotherapy in gastric cancer: a systematic review of literature and new perspectives . Expert Rev. Anticancer Ther.7 ( 10 ), 1379 – 1393 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Qiu H , YashiroM , ShintoO , MatsuzakiT , HirakawaK . DNA methyltransferase inhibitor 5-aza-CdR enhances the radiosensitivity of gastric cancer cells . Cancer Sci.100 ( 1 ), 181 – 188 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Huang YH , SuJ , LeiYet al. DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A . Genome Biol.18 ( 1 ), 176 ( 2017 ).
   PubMedGoogle Scholar
• Mcdonald JI , CelikH , RoisLEet al. Reprogrammable CRISPR/Cas9-based system for inducing site-specific DNA methylation . Biol. Open5 ( 6 ), 866 – 874 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Vojta A , DobrinicP , TadicVet al. Repurposing the CRISPR-Cas9 system for targeted DNA methylation . Nucleic Acids Res.44 ( 12 ), 5615 – 5628 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Liu XS , WuH , JiXet al. Editing DNA methylation in the mammalian genome . Cell167 ( 1 ), 233 – 247 ; e217 ( 2016 ).
   PubMed Web of Science ®Google Scholar